Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CABA Cabaletta Bio

交易中 04-22 15:10:41 EDT

1.28

+0.11

+9.40%

最高1.31	最低1.15	成交量79.08万
今开1.18	昨收1.17	日振幅13.43%
总市值6,495万	流通市值5,482万	总股本5,074万
成交额99.26万	换手率1.85%	流通股本4,283万
市净率0.43	ROE-59.64%	每股收益-2.36
52周最高14.02	52周最低0.9857	市盈率-0.54
股息0.00	股息收益率0.00	ROA-35.66%

北京优虎网络科技有限公司

{"stockData":{"symbol":"CABA","market":"US","secType":"STK","nameCN":"Cabaletta Bio","latestPrice":1.28,"timestamp":1745349011988,"preClose":1.17,"halted":0,"volume":790777,"delay":0,"floatShares":42831942,"shares":50743101,"eps":-2.362704,"marketStatus":"交易中","change":0.11,"latestTime":"04-22 15:10:40 EDT","open":1.18,"high":1.3075,"low":1.1504,"amount":992578.0712718,"amplitude":0.134274,"askPrice":1.29,"askSize":288,"bidPrice":1.28,"bidSize":2649,"shortable":3,"etf":0,"ttmEps":-2.362704,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"listingDate":1571976000000,"exchange":"NASDAQ","adjPreClose":1.17,"preHourTrading":{"tag":"盘前","latestPrice":1.17,"preClose":1.17,"latestTime":"09:26 EDT","volume":45,"amount":52.599996,"timestamp":1745328412080},"postHourTrading":{"tag":"盘后","latestPrice":1.2332,"preClose":1.17,"latestTime":"19:52 EDT","volume":3059,"amount":3619.38,"timestamp":1745279577168},"volumeRatio":1.119542,"impliedVol":7.6278,"impliedVolPercentile":0.992},"requestUrl":"/m/hq/s/CABA","defaultTab":"news","newsList":[{"id":"2529827955","title":"Cabaletta Bio, Inc.盘中异动 大幅上涨5.13%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529827955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529827955?lang=zh_cn&edition=full","pubTime":"2025-04-22 22:24","pubTimestamp":1745331895,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日22时24分，Cabaletta Bio, Inc.股票出现异动，股价快速拉升5.13%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.59%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222224559740c7c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222224559740c7c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2528877386","title":"Cabaletta Bio, Inc.盘中异动 临近收盘急速拉升5.09%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528877386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528877386?lang=zh_cn&edition=full","pubTime":"2025-04-18 03:42","pubTimestamp":1744918936,"startTime":"0","endTime":"0","summary":"北京时间2025年04月18日03时42分，Cabaletta Bio, Inc.股票出现波动，股价大幅拉升5.09%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041803421694d91e61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041803421694d91e61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2528273255","title":"Cabaletta Bio, Inc.盘中异动 下午盘大幅跳水5.19%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528273255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528273255?lang=zh_cn&edition=full","pubTime":"2025-04-17 01:48","pubTimestamp":1744825713,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日01时48分，Cabaletta Bio, Inc.股票出现波动，股价急速跳水5.19%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.55%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041701483394d7b49f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041701483394d7b49f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2527115322","title":"Cabaletta Bio, Inc.盘中异动 大幅跳水5.28%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527115322","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527115322?lang=zh_cn&edition=full","pubTime":"2025-04-15 00:50","pubTimestamp":1744649402,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日00时50分，Cabaletta Bio, Inc.股票出现异动，股价快速跳水5.28%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为2.14%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504150050029737a1db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504150050029737a1db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2518204985","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.14%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518204985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518204985?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:07","pubTimestamp":1741633666,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时07分，Cabaletta Bio, Inc.股票出现异动，股价大幅下挫5.14%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311030746abf37776&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311030746abf37776&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2517925605","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.01%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517925605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517925605?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:39","pubTimestamp":1741203592,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时39分，Cabaletta Bio, Inc.股票出现波动，股价快速上涨5.01%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.96%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306033952989d886d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306033952989d886d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2517605283","title":"Cabaletta Bio, Inc.盘中异动 大幅拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517605283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517605283?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:49","pubTimestamp":1741103373,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时49分，Cabaletta Bio, Inc.股票出现异动，股价快速上涨5.09%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304234933a25f1a3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304234933a25f1a3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2516654554","title":"Cabaletta Bio, Inc.盘中异动 下午盘大幅跳水5.24%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516654554?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:20","pubTimestamp":1741026001,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时20分，Cabaletta Bio, Inc.股票出现异动，股价急速跳水5.24%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022001abe675dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022001abe675dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2514738903","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514738903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514738903?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:34","pubTimestamp":1740753266,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时34分，Cabaletta Bio, Inc.股票出现波动，股价快速下挫5.23%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822342696341a15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822342696341a15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2514862257","title":"Cabaletta Bio, Inc.盘中异动 临近收盘急速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514862257?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:30","pubTimestamp":1740601806,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时30分，Cabaletta Bio, Inc.股票出现异动，股价急速下跌5.05%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227043006abde3ace&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227043006abde3ace&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2513720852","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720852?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:57","pubTimestamp":1740409041,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时57分，Cabaletta Bio, Inc.股票出现异动，股价快速下挫5.34%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225721962e9f56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225721962e9f56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2512486563","title":"Cabaletta Bio, Inc.盘中异动 快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512486563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512486563?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:15","pubTimestamp":1739978156,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时15分，Cabaletta Bio, Inc.股票出现波动，股价大幅跳水5.15%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192315569628d512&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192315569628d512&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2512165328","title":"Cabaletta Bio, Inc.盘中异动 大幅上涨5.17%报2.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165328?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:38","pubTimestamp":1739889482,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时38分，Cabaletta Bio, Inc.股票出现异动，股价急速拉升5.17%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182238029889fe36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182238029889fe36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2511929816","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大涨5.00%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511929816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511929816?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:51","pubTimestamp":1739548284,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时51分，Cabaletta Bio, Inc.股票出现异动，股价大幅拉升5.00%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214235125a246130c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214235125a246130c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2511525110","title":"Cabaletta Bio, Inc.盘中异动 早盘快速上涨5.24%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511525110?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:41","pubTimestamp":1739457700,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时41分，Cabaletta Bio, Inc.股票出现波动，股价大幅拉升5.24%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322414198842dcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322414198842dcb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2510838707","title":"Cabaletta Bio, Inc.盘中异动 快速下跌5.14%报2.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510838707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510838707?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:32","pubTimestamp":1739284363,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时32分，Cabaletta Bio, Inc.股票出现异动，股价大幅下挫5.14%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.10%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223244abcb065e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223244abcb065e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2510990798","title":"Cabaletta Bio, Inc.盘中异动 快速下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510990798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510990798?lang=zh_cn&edition=full","pubTime":"2025-02-11 03:11","pubTimestamp":1739214702,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日03时11分，Cabaletta Bio, Inc.股票出现波动，股价快速下挫5.09%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110311439880ae1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110311439880ae1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2509420817","title":"Cabaletta Bio, Inc.盘中异动 早盘大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509420817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509420817?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:54","pubTimestamp":1738940044,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时54分，Cabaletta Bio, Inc.股票出现异动，股价急速上涨5.00%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225404987db19f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225404987db19f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2509204947","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509204947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509204947?lang=zh_cn&edition=full","pubTime":"2025-02-07 01:36","pubTimestamp":1738863363,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日01时36分，Cabaletta Bio, Inc.股票出现异动，股价快速拉升5.12%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207013604abc4f9cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207013604abc4f9cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2509258261","title":"Cabaletta Bio, Inc.盘中异动 急速拉升5.17%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509258261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509258261?lang=zh_cn&edition=full","pubTime":"2025-02-06 03:26","pubTimestamp":1738783619,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日03时26分，Cabaletta Bio, Inc.股票出现波动，股价大幅上涨5.17%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为2.43%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206032659a23ab888&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206032659a23ab888&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cabalettabio.com","stockEarnings":[{"period":"1week","weight":0.0043},{"period":"1month","weight":-0.3276},{"period":"3month","weight":-0.55},{"period":"6month","weight":-0.7097},{"period":"1year","weight":-0.9123},{"period":"ytd","weight":-0.4846}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cabaletta Bio, Inc.于2017年4月根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，专注于发现和开发工程化T细胞疗法，这些疗法有可能为患有自身免疫性疾病的患者提供一种深度和持久的，也许是治疗性的治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.048317},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.157271},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.183657},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.100077},{"month":5,"riseRate":0.4,"avgChangeRate":0.011007},{"month":6,"riseRate":0.4,"avgChangeRate":-0.019407},{"month":7,"riseRate":0.6,"avgChangeRate":0.002175},{"month":8,"riseRate":0.4,"avgChangeRate":-0.014107},{"month":9,"riseRate":0.6,"avgChangeRate":-0.036797},{"month":10,"riseRate":0.6,"avgChangeRate":0.296033},{"month":11,"riseRate":0.833333,"avgChangeRate":0.381738},{"month":12,"riseRate":0.5,"avgChangeRate":0.043168}],"exchange":"NASDAQ","name":"Cabaletta Bio","nameEN":"Cabaletta Bio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cabaletta Bio(CABA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cabaletta Bio,CABA,Cabaletta Bio股票,Cabaletta Bio股票老虎,Cabaletta Bio股票老虎国际,Cabaletta Bio行情,Cabaletta Bio股票行情,Cabaletta Bio股价,Cabaletta Bio股市,Cabaletta Bio股票价格,Cabaletta Bio股票交易,Cabaletta Bio股票购买,Cabaletta Bio股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cabaletta Bio(CABA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}